157 related items for PubMed ID: 29080118
1. Immunosuppressive therapy for steroid-resistant nephrotic syndrome: a Bayesian network meta-analysis of randomized controlled studies.
Jiang X, Shen W, Xu X, Shen X, Li Y, He Q.
Clin Exp Nephrol; 2018 Jun; 22(3):562-569. PubMed ID: 29080118
[Abstract] [Full Text] [Related]
2. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Wong SC, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
[Abstract] [Full Text] [Related]
3. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2010 Nov 10; (11):CD003594. PubMed ID: 21069676
[Abstract] [Full Text] [Related]
4. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Habashy D, Hodson E, Craig J.
Cochrane Database Syst Rev; 2004 Nov 10; (2):CD003594. PubMed ID: 15106208
[Abstract] [Full Text] [Related]
5. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Habashy D, Craig JC.
Cochrane Database Syst Rev; 2006 Apr 19; (2):CD003594. PubMed ID: 16625586
[Abstract] [Full Text] [Related]
6. Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis.
Fu HD, Qian GL, Jiang ZY.
J Investig Med; 2017 Jan 19; 65(1):65-71. PubMed ID: 27489255
[Abstract] [Full Text] [Related]
7. Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis.
Li HY, Zhang X, Zhou T, Zhong Z, Zhong H.
BMC Nephrol; 2019 Oct 23; 20(1):384. PubMed ID: 31646979
[Abstract] [Full Text] [Related]
8. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
Kidney Int; 2012 Nov 23; 82(10):1130-5. PubMed ID: 22763815
[Abstract] [Full Text] [Related]
9. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May 23; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
10. Interventions for steroid-resistant nephrotic syndrome: a systematic review.
Habashy D, Hodson EM, Craig JC.
Pediatr Nephrol; 2003 Sep 23; 18(9):906-12. PubMed ID: 12836096
[Abstract] [Full Text] [Related]
11. Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis.
Li S, Yang H, Guo P, Ao X, Wan J, Li Q, Tan L.
Oncotarget; 2017 Sep 22; 8(42):73050-73062. PubMed ID: 29069848
[Abstract] [Full Text] [Related]
12. [Efficacy and safety of cyclosporine A in treatment of refractory nephrotic syndrome in children: a systematic review of randomized controlled trials].
Chen LZ, Jiang XY, Lu HY, Zhang QL, Mo Y.
Zhonghua Er Ke Za Zhi; 2009 Dec 22; 47(12):898-903. PubMed ID: 20193140
[Abstract] [Full Text] [Related]
13. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S, Wang Y, Xian L, Toyama T, Jardine M, Li G, Perkovic V, Hong D.
PLoS One; 2017 Dec 22; 12(9):e0184398. PubMed ID: 28898290
[Abstract] [Full Text] [Related]
14. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
Am J Kidney Dis; 2009 Jul 22; 54(1):51-8. PubMed ID: 19406543
[Abstract] [Full Text] [Related]
15. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH, Song GG.
Lupus; 2015 Dec 22; 24(14):1520-8. PubMed ID: 26162684
[Abstract] [Full Text] [Related]
16. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q, Yang H, Liu W, Sun W, Zhao Q, Zhang X, Jin H, Sun L.
BMJ Open; 2019 Sep 11; 9(9):e030919. PubMed ID: 31511292
[Abstract] [Full Text] [Related]
17. Therapies for steroid-resistant nephrotic syndrome.
Hodson EM, Craig JC.
Pediatr Nephrol; 2008 Sep 11; 23(9):1391-4. PubMed ID: 18368428
[Abstract] [Full Text] [Related]
18. A new 'tac' for childhood nephrotic syndrome.
Becknell B, Greenbaum LA, Smoyer WE.
Kidney Int; 2012 Nov 11; 82(10):1049-51. PubMed ID: 23128115
[Abstract] [Full Text] [Related]
19. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul 11; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
20. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan 11; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
